Moloney, C., Zhao, Z., Shilatifard, A., Meeks, J. J., VanderWeele, D. J., Demir, T., Brown, T. D., Chen, R., Chae, Y. K., Kalyan, A., Peng, C., Mulcahy, M. F., Mahalingam, D. (2025). A phase II trial to evaluate clinical efficacy, pharmacodynamics and exploratory analysis of pemetrexed in relation to MLL4 and UTX alteration status in patients with relapsed/refractory metastatic urothelial carcinoma and other solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4621